High-Fiber Plant-Based Diet Shows Potential in Delaying Progression of Precancerous Conditions Linked to Multiple Myeloma

A recent clinical trial has indicated that a high-fiber, plant-based diet may offer potential benefits for individuals at risk of developing multiple myeloma, the second most common type of blood cancer. Researchers found that the dietary approach was both feasible and well-received by participants, while also demonstrating improvements in several factors associated with delaying the progression of precancerous conditions linked to multiple myeloma.

The study explored whether dietary interventions could play a role in managing risks related to this form of blood cancer. Participants adhered to a plant-based diet rich in fiber, and researchers monitored its impact on health markers relevant to disease progression. The findings revealed that the diet positively influenced key factors tied to precancerous conditions, suggesting it may hold promise as part of broader strategies aimed at reducing risks associated with multiple myeloma.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 5, 2025

Related posts:

Generic Drug Market Poised for Growth: Over 200 Brand-Name Drugs to Lose Patent Protection by 2027. City and County Health Officials Criticize Unspecified Mass Layoffs of Federal Health Workers Specialty Pharmacies Expand Role in Rare Disease Care as Pharma Industry Tackles Rising Clinical Trial Costs UC Davis Experts Warn Pesticides May Drive Antifungal Resistance, Advocate One Health Strategy

Author

Mark Chiang